Evidence map›Paper›PMID 39707360›Full record

ArticleHarm reduction journal2024

Developing an ethical framework for the recruitment of people who inject drugs experiencing incarceration in HIV prevention research: a qualitative study.

Matthew Murphy, Nyx Gomes, Kimberly Kane, Josiah D Rich, Lloyd Goldsamt, Jasjit S Ahluwalia, Kate M Guthrie, Susan E Ramsey, Sara Vargas

Abstract read
In one paragraph

Article in Harm reduction journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Matthew MurphyLifespan, Providence, RI, USA.
Nyx GomesLifespan, Providence, RI, USA. mgomes19@lifespan.org.
Kimberly KaneRhode Island Department of Corrections, Cranston, RI, USA.
Josiah D RichLifespan, Providence, RI, USA.
Lloyd GoldsamtNew York University, New York, NY, USA.
Jasjit S AhluwaliaAlpert Medical School of Brown University, Providence, RI, USA.
Kate M GuthrieLifespan, Providence, RI, USA.
Susan E RamseyLifespan, Providence, RI, USA.
Sara VargasLifespan, Providence, RI, USA.

Funding

Translational ScienceP30AI042853 · NIAID · MIRIAM HOSPITAL · PI CURT G BECKWITH · 1998 to 2026
$51.7M
Using wearables and EMA to examine the links between cannabis and depressionP20GM130414 · NIGMS · BROWN UNIVERSITY · PI Tyler Blake Wray · 2019 to 2026
$22.0M
Training Program in HIV Prevention Research EthicsR25DA031608 · NIDA · FORDHAM UNIVERSITY · PI FISHER, CELIA B · 2011 to 2025
$4.9M
An intervention to improve HIV pre-exposure prophylaxis initiation, adherence and linkage to care for recently incarcerated men who inject drugs.K23DA054003 · NIDA · RHODE ISLAND HOSPITAL · PI Matthew Murphy · 2022 to 2026
$977k
HIV and Drug Abuse Prevention Research Ethics Training Institute, Fordham University R25DA031608National Institute of Allergy and Infectious Diseases P30AI042853NIAID NIH HHS P30 AI042853NIDA NIH HHS K23 DA054003NIDA NIH HHS K23DA054003NIDA NIH HHS L30 DA052067NIDA NIH HHS R25 DA031608NIGMS NIH HHS P20 GM130414NIGMS NIH HHS P20GM130414
6 · The paper itself

Abstract

backgroundHIV disproportionately impacts people who experience incarceration. Incarceration represents an opportunity to engage in HIV prevention care for individuals who often experience a number of barriers accessing health services in the community. The development of evidence-based practices promoting pre-exposure prophylaxis for HIV prevention (PrEP) is crucial for ending the HIV epidemic within this highly marginalized population. However, PrEP research within carceral facilities has been limited and is hampered in part by the lack of ethical guidance on conducting HIV prevention research in this unique setting where incarcerated individuals are categorized as a vulnerable population requiring specific protections. This lack of knowledge is particularly striking when considering the lack of input from incarcerated individuals themselves on the responsible conduct of research, which is critical to understanding ways to ensure participant autonomy while avoiding coercive practices in research activities.

methodsIn order to gain a better understanding of ethical approaches to the conduct of HIV prevention research among incarcerated individuals, we conducted qualitative interviews with 21 incarcerated men who reported injecting drugs and met clinical criteria for PrEP use. The interview topics included HIV knowledge, PrEP knowledge, stigma, and perceptions related to ethical research practices.

resultsThemes identified included how forced abstinence during incarceration can negatively affect research participation, the importance of participant comfort as it relates to ensuring autonomy in decision making, a desire for person centred approaches in research activities, study staff characteristics impacting participant experience, and perceptions of carceral staff as members of research teams.

conclusionsThe results of this study indicate that conducting research focused on improving PrEP use in a carceral environment has support among those experiencing incarceration. However, researchers should place the participant experience at the center of research protocol development.

Indexed as

HIV InfectionsPre-Exposure ProphylaxisPrisonersQualitative ResearchSubstance Abuse, IntravenousAdultHealth Knowledge, Attitudes, PracticeHumansIncarcerationMaleMiddle AgedPatient SelectionSocial StigmaHIVIncarcerationPrEPQualitative researchResearch ethicsSubstance use

Identifiers

PMID39707360
PMCPMC11660855

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.